AR015105A1 - Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende - Google Patents

Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende

Info

Publication number: AR015105A1
Authority: AR; Argentina
Prior art keywords: growth; neurites; stimulate; understands; medicine
Prior art date: 1996-11-13

Application number

ARP970105320A

Other languages

English (en)

Spanish (es)

Original Assignee

Vertex Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-13

Filing date

1997-11-13

Publication date

2001-04-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25012320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015105(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-13 Application filed by Vertex Pharma filed Critical Vertex Pharma

2001-04-18 Publication of AR015105A1 publication Critical patent/AR015105A1/es

Links

108010025020 Nerve Growth Factor Proteins 0.000 title abstract 5
239000000203 mixture Substances 0.000 title abstract 5
102000007072 Nerve Growth Factors Human genes 0.000 title abstract 3
239000003900 neurotrophic factor Substances 0.000 title abstract 3
210000002241 neurite Anatomy 0.000 title abstract 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
239000004202 carbamide Substances 0.000 title 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title 1
210000004027 cell Anatomy 0.000 title 1
102000015336 Nerve Growth Factor Human genes 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229940053128 nerve growth factor Drugs 0.000 abstract 2
210000002569 neuron Anatomy 0.000 abstract 2
208000014674 injury Diseases 0.000 abstract 1
230000003961 neuronal insult Effects 0.000 abstract 1
230000000508 neurotrophic effect Effects 0.000 abstract 1
230000008733 trauma Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

ARP970105320A 1996-11-13 1997-11-13 Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende AR015105A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/749,114 US5780484A (en)	1996-11-13	1996-11-13	Methods for stimulating neurite growth with piperidine compounds

Publications (1)

Publication Number	Publication Date
AR015105A1 true AR015105A1 (es)	2001-04-18

Family

ID=25012320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ARP970105320A AR015105A1 (es)	1996-11-13	1997-11-13	Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende

Country Status (19)

Country	Link
US (1)	US5780484A (2)
EP (2)	EP1666053A1 (2)
JP (1)	JP2001503778A (2)
KR (1)	KR100537866B1 (2)
CN (1)	CN1168443C (2)
AR (1)	AR015105A1 (2)
AU (1)	AU741186B2 (2)
BR (1)	BR9713037A (2)
CA (1)	CA2270985A1 (2)
CO (1)	CO5080733A1 (2)
EA (1)	EA003530B1 (2)
IL (1)	IL129557A0 (2)
IN (1)	IN183409B (2)
NZ (1)	NZ335396A (2)
PL (1)	PL191249B1 (2)
TW (1)	TW509572B (2)
UA (1)	UA61090C2 (2)
WO (1)	WO1998020893A1 (2)
ZA (1)	ZA9710248B (2)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6133456A (en) *	1994-08-18	2000-10-17	Ariad Gene Therapeutics, Inc.	Synthetic multimerizing agents
US6150527A (en) *	1994-08-18	2000-11-21	Ariad Pharmaceuticals, Inc.	Synthetic multimerizing agents
US20030036654A1 (en) *	1994-08-18	2003-02-20	Holt Dennis A.	Synthetic multimerizing agents
US5859031A (en)	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
US6242468B1 (en)	1997-02-27	2001-06-05	Jia-He Li	Carbamate and urea compositions and neurotrophic uses
ZA98825B (en) *	1997-02-27	1998-10-19	Guilford Pharm Inc	Method of using neurotrophic carbamates and ureas
US6514686B2 (en)	1997-04-28	2003-02-04	The University Of British Columbia	Method and composition for modulating amyloidosis
US20010049381A1 (en)	1997-06-04	2001-12-06	Gpl Nil Holdings, Inc.,	Pyrrolidine derivative hair growth compositions and uses
US5945441A (en)	1997-06-04	1999-08-31	Gpi Nil Holdings, Inc.	Pyrrolidine carboxylate hair revitalizing agents
US6852496B1 (en) *	1997-08-12	2005-02-08	Oregon Health And Science University	Methods of screening for agents that promote nerve cell growth
US5968921A (en)	1997-10-24	1999-10-19	Orgegon Health Sciences University	Compositions and methods for promoting nerve regeneration
PL348671A1 (en) *	1998-06-03	2002-06-03	Gpi Nil Holdings	Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
US6331537B1 (en)	1998-06-03	2001-12-18	Gpi Nil Holdings, Inc.	Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
CN1295561A (zh)	1998-06-03	2001-05-16	Gpinil控股公司	N－杂环羧酸或羧酸等排物的n－结合氨磺酰
PT1098897E (pt)	1998-07-17	2004-10-29	Agouron Pharma	Compostos composicoes e metodos para estimular o crescimento e a elongacao neuronal
GB9815880D0 (en)	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles
US6376517B1 (en) *	1998-08-14	2002-04-23	Gpi Nil Holdings, Inc.	Pipecolic acid derivatives for vision and memory disorders
US7338976B1 (en) *	1998-08-14	2008-03-04	Gpi Nil Holdings, Inc.	Heterocyclic esters or amides for vision and memory disorders
US6395758B1 (en)	1998-08-14	2002-05-28	Gpi Nil Holdings, Inc.	Small molecule carbamates or ureas for vision and memory disorders
US6462072B1 (en)	1998-09-21	2002-10-08	Gpi Nil Holdings, Inc.	Cyclic ester or amide derivatives
US6228872B1 (en) *	1998-11-12	2001-05-08	Bristol-Myers Squibb Company	Neurotrophic diamide and carbamate agents
WO2001002368A1 (en) *	1999-07-06	2001-01-11	Vertex Pharmaceuticals Incorporated	N-heterocyclic derivatives with neuronal activity
US6809107B1 (en) *	1999-07-09	2004-10-26	Ortho-Mcneil Pharmaceutical, Inc.	Neurotrophic pyrrolidines and piperidines, and related compositions and methods
US6734211B1 (en)	1999-07-09	2004-05-11	Oregon Health & Sciences University	Compositions and methods for promoting nerve regeneration
WO2001017953A1 (en)	1999-09-08	2001-03-15	Guilford Pharmaceuticals Inc.	Non-peptidic cyclophilin binding compounds and their use
HK1046108B (en) *	1999-11-12	2007-01-05	Alcon, Inc.	Neurophilin ligands for treating ocular conditions
US6417189B1 (en)	1999-11-12	2002-07-09	Gpi Nil Holdings, Inc.	AZA compounds, pharmaceutical compositions and methods of use
US7253169B2 (en)	1999-11-12	2007-08-07	Gliamed, Inc.	Aza compounds, pharmaceutical compositions and methods of use
US6818643B1 (en)	1999-12-08	2004-11-16	Bristol-Myers Squibb Company	Neurotrophic bicyclic diamides
CA2393466C (en)	1999-12-21	2010-01-19	Gpi Nil Holdings, Inc.	Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
JP2004532187A (ja)	2001-01-25	2004-10-21	ギルフォードファーマシュウティカルズインコーポレイテッド	三置換カルボサイクリックサイクロフィリン結合化合物とその用途
WO2002096420A2 (en) *	2001-05-29	2002-12-05	Guilford Pharmaceuticals Inc.	Method for treating nerve injury caused by surgery
US20040147433A1 (en) *	2001-06-14	2004-07-29	Marcus Keep	Neuroimmunophilins for selective neuronal radioprotection
WO2003062773A1 (en) *	2002-01-24	2003-07-31	Pei Electronics, Inc.	Compact integrated infrared scene projector
MXPA05003471A (es) *	2002-10-03	2005-07-01	Vertex Pharma	Derivados de piperazina y piperadina para el tratamiento de enfermedades neurologicas.
US20060189551A1 (en) *	2004-10-04	2006-08-24	Duke University	Combination therapies for fungal pathogens
AU2005319454B2 (en) *	2004-12-20	2012-08-09	Wyeth	Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
CA2590254A1 (en) *	2004-12-20	2006-06-29	Wyeth	Rapamycin derivatives and the uses thereof in the treatment of neurological disorders
ES2528674T3 (es) *	2005-02-17	2015-02-11	Astellas Pharma Inc.	Piperidina y carboxilatos de piperacina como inhibidores de FAAH
EP1988920A1 (en) *	2006-02-02	2008-11-12	Rinat Neuroscience Corp.	Methods for treating obesity by administering a trkb antagonist
EP1988923A1 (en) *	2006-02-02	2008-11-12	Rinat Neuroscience Corp.	Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist
CN112218683A (zh)	2018-05-30	2021-01-12	睿谱外科系统股份有限公司	靠近关键结构的辐射外科手术神经调节
CN116763768B (zh) *	2022-03-15	2026-03-20	润佳（苏州）医药科技有限公司	同位素富集的3-氨基-1-丙磺酸衍生物及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5192773A (en) *	1990-07-02	1993-03-09	Vertex Pharmaceuticals, Inc.	Immunosuppressive compounds
ES2137186T3 (es) *	1991-05-09	1999-12-16	Vertex Pharma	Nuevos compuestos inmunosupresores.
NZ314207A (en) *	1992-09-28	2000-12-22	Vertex Pharma	1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5744485A (en) *	1994-03-25	1998-04-28	Vertex Pharmaceuticals Incorporated	Carbamates and ureas as modifiers of multi-drug resistance
IL115685A (en) *	1994-11-16	2000-08-31	Vertex Pharma	Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US5543423A (en) *	1994-11-16	1996-08-06	Vertex Pharmaceuticals, Incorporated	Amino acid derivatives with improved multi-drug resistance activity
US5726184A (en) *	1995-05-19	1998-03-10	Vertex Pharmaceuticals Incorporated	Tetralin compounds with improved MDR activity
US5614547A (en) *	1995-06-07	1997-03-25	Guilford Pharmaceuticals Inc.	Small molecule inhibitors of rotamase enzyme
US5696135A (en) *	1995-06-07	1997-12-09	Gpi Nil Holdings, Inc.	Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) *	1995-06-07	1999-01-12	Gpi Nil Holdings, Inc.	Small molecule inhibitors of rotamase enzyme activity
US6037370A (en) *	1995-06-08	2000-03-14	Vertex Pharmaceuticals Incorporated	Methods and compositions for stimulating neurite growth
US5801197A (en) *	1995-10-31	1998-09-01	Gpi Nil Holdings, Inc.	Rotamase enzyme activity inhibitors
US5811434A (en) *	1996-11-13	1998-09-22	Vertex Pharmacueticals Incorporated	Methods and compositions for stimulating neurite growth
US5840736A (en) *	1996-11-13	1998-11-24	Vertex Pharmaceuticals Incorporated	Methods and compositions for stimulating neurite growth
US9604852B2 (en) *	2012-09-28	2017-03-28	Dic Corporation	α-alumina particles and method for manufacturing the same

1996
- 1996-11-13 US US08/749,114 patent/US5780484A/en not_active Expired - Lifetime
1997
- 1997-11-13 AR ARP970105320A patent/AR015105A1/es not_active Application Discontinuation
- 1997-11-13 TW TW086116912A patent/TW509572B/zh not_active IP Right Cessation
- 1997-11-13 CA CA002270985A patent/CA2270985A1/en not_active Abandoned
- 1997-11-13 ZA ZA9710248A patent/ZA9710248B/xx unknown
- 1997-11-13 KR KR10-1999-7004194A patent/KR100537866B1/ko not_active Expired - Fee Related
- 1997-11-13 UA UA99063269A patent/UA61090C2/uk unknown
- 1997-11-13 EP EP06000328A patent/EP1666053A1/en not_active Ceased
- 1997-11-13 BR BR9713037-0A patent/BR9713037A/pt not_active Application Discontinuation
- 1997-11-13 CN CNB971802483A patent/CN1168443C/zh not_active Expired - Fee Related
- 1997-11-13 JP JP52286798A patent/JP2001503778A/ja active Pending
- 1997-11-13 NZ NZ335396A patent/NZ335396A/xx unknown
- 1997-11-13 EP EP97948309A patent/EP0941113A1/en not_active Ceased
- 1997-11-13 WO PCT/US1997/020868 patent/WO1998020893A1/en not_active Ceased
- 1997-11-13 IN IN2147CA1997 patent/IN183409B/en unknown
- 1997-11-13 EA EA199900463A patent/EA003530B1/ru not_active IP Right Cessation
- 1997-11-13 PL PL333286A patent/PL191249B1/pl not_active IP Right Cessation
- 1997-11-13 AU AU54397/98A patent/AU741186B2/en not_active Ceased
- 1997-11-13 CO CO97066753A patent/CO5080733A1/es unknown
- 1997-11-13 IL IL12955797A patent/IL129557A0/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR9713037A (pt)	2000-04-11
US5780484A (en)	1998-07-14
JP2001503778A (ja)	2001-03-21
AU5439798A (en)	1998-06-03
AU741186B2 (en)	2001-11-22
WO1998020893A1 (en)	1998-05-22
KR100537866B1 (ko)	2005-12-21
CN1168443C (zh)	2004-09-29
IL129557A0 (en)	2000-02-29
EP0941113A1 (en)	1999-09-15
CA2270985A1 (en)	1998-05-22
NZ335396A (en)	2000-11-24
EP1666053A1 (en)	2006-06-07
IN183409B (2)	1999-12-25
UA61090C2 (uk)	2003-11-17
PL333286A1 (en)	1999-11-22
CO5080733A1 (es)	2001-09-25
ZA9710248B (en)	1998-05-28
EA199900463A1 (ru)	2000-02-28
TW509572B (en)	2002-11-11
KR20000068964A (ko)	2000-11-25
PL191249B1 (pl)	2006-04-28
EA003530B1 (ru)	2003-06-26
CN1239434A (zh)	1999-12-22

Legal Events

Date	Code	Title	Description
2010-05-18	FC	Refusal

Publication	Publication Date	Title
AR015105A1 (es)	2001-04-18	Una composicion que comprende derivados de urea o carbonato y factores neurotroficos para estimular el crecimiento de neuritas en celulas nerviosas y unmedicamento que la comprende
AR013873A1 (es)	2001-01-31	Una composicion que comprende derivados de tetralina y factores ico neurologicos para estimular el crecimiento de neuritas en celulas nerviosas
TR199901034T2 (xx)	1999-07-21	N�rit b�y�mesinin uyar�lmas� i�in y�ntemler ve bile�imler.
MX9203653A (es)	1992-09-01	Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
BRPI0511132A (pt)	2007-11-27	derivados de pirimidina e composição farmacêutica compreendendo os mesmos
BR0116402A (pt)	2003-11-11	Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
ES2154287T3 (es)	2001-04-01	Procedimiento para modificar el crecimiento de los pelos y/o de los cabellos y composiciones utilizables a este efecto.
BR0013081A (pt)	2002-04-23	Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
MX9206577A (es)	1993-05-01	COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
CA2120303A1 (en)	1994-10-02	Cyclic adhesion inhibitors
PA8432901A1 (es)	2000-05-24	Compuestos de piridilpirrol
ES2052603T3 (es)	1994-07-16	Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2089687T3 (es)	1996-10-01	4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
AR016875A1 (es)	2001-08-01	Un amino-derivado que posee actividad neuronal, una composicion que lo contiene y usos de los mismos para estimular la actividad neuronal
ES2061118T3 (es)	1994-12-01	N-oxidos de piridinas sustituidas en posiciones 2,4 y 2,5, procedimiento para su preparacion, asi como su utilizacion.
DE59906391D1 (de)	2003-08-28	Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure
ES2038092T1 (es)	1993-07-16	Un compuesto de dioxetano.
ES2055319T3 (es)	1994-08-16	Composiciones quimicas de base acuosa.
DK513384D0 (da)	1984-10-26	Griseolsyrederivater og deres anvendelse
ES2093944T3 (es)	1997-01-01	Composicion cosmetica y/o dermatologica de accion despigmentante que contiene un acido di- o tri-cafeoilquinico o una mezcla de estos.
ES2130587T3 (es)	1999-07-01	Composiciones antimicrobianas sinergicas que contienen metilen-bis(tiocianato) y un acido organico.
DE602004027367D1 (de)	2010-07-08	Chinazolinonderivate und deren verwendung zur herstellung von pharmazeutischen zusammensetzungen mit parp-inhibierender wirkung
BR0309456A (pt)	2007-03-06	agentes de proliferação de células
BR9915900A (pt)	2001-08-21	Composto, composição farmacêutica, e, processo para tratar ou inibir distúrbios associados com contração da musculatura lisa.
ES2040294T3 (es)	1993-10-16	Nuevos compuestos de azufre, procedimientos para su preparacion, asi como medicamentos.